Bristol-Myers Squibb Company News Headlines

BMY 
$47.4
*  
0.40
  negative  
0.85%
Get BMY Alerts
*Delayed - data as of May 24, 2013 
Exchange: NYSE
Industry: Consumer Durables
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Bristol-Myers Net Drops on Lower Sales of Heart Drugs
4/25/2013 8:45:00 AM - Dow Jones Business News

Bristol-Myers Q1 Profit Down; Confirms FY13 Profit View - Quick Facts
4/25/2013 7:55:00 AM - RTT News

Bristol-Myers 1st-Quarter Net Drops 45% on Lower Sales of Heart Drugs
4/25/2013 7:45:00 AM - Dow Jones Business News

Cramer's Mad Money - National Lemming Day (4/24/13)
4/25/2013 6:52:00 AM - Seeking Alpha

Gilead Reports Encouraging HCV Data - Analyst Blog
4/24/2013 7:10:53 PM - Zacks.com

Whisper Number Impact: Earnings Preview For Bristol-Myers Squibb
4/24/2013 4:40:00 PM - Seeking Alpha

Pre-Market Earnings Report for April 25, 2013 : XOM, MMM, MO, COP, BMY, OXY, UPS, CL, CELG, BIIB, DOW, D
4/24/2013 4:00:04 PM - NASDAQ.com News

Bristol-Myers Squibb Preview: Performance Of New Drugs Is Key
4/24/2013 3:50:00 PM - Seeking Alpha

UPDATE: FDA Gives 'Breakthrough' Designation to Merck Skin-Cancer Drug
4/24/2013 10:10:00 AM - Dow Jones Business News

UPDATE: Eli Lilly 1st-Quarter Net Rose 53% on Gain; Revenue Flat
4/24/2013 8:56:00 AM - Dow Jones Business News

FDA Gives 'Breakthrough' Designation to Merck Skin-Cancer Drug
4/23/2013 9:15:00 PM - Dow Jones Business News

Merck - BMY in HCV Deal - Analyst Blog
4/23/2013 6:09:40 PM - Zacks.com

Vertex Pharma Says VX-135 Holds Promise For Hepatitis C
4/23/2013 9:52:00 AM - RTT News

Bristol Says Results of Hepatitis C Drug Trial are Positive
4/23/2013 6:14:00 AM - Dow Jones Business News

SSRX' Revised Go-private Offer, Red Flag For IBIO, TTNP, VPHM To Watch Out For
4/22/2013 11:21:00 PM - RTT News

Bristol-Myers Likely to Report In Line Earnings - Analyst Blog
4/22/2013 4:09:40 PM - Zacks.com

Merck-Bristol-Myers' Phase II Trial To Check Hepatitis C Candidates' Combination
4/22/2013 8:41:00 AM - RTT News

Merck, Bristol-Myers to Jointly Study Potential Hepatitis C Virus Drug
4/22/2013 8:03:00 AM - Dow Jones Business News

Merck Enters Agreement With Bristol-Myers To Conduct Phase II Clinical Trial
4/22/2013 7:46:00 AM - RTT News

Correction to Reckitt Sales story
4/22/2013 3:08:00 AM - Dow Jones Business News

Flu Season Momentum Boosts Reckitt Sales
4/22/2013 2:45:00 AM - Dow Jones Business News

BMY, Santaris Pharma Team Up - Analyst Blog
4/19/2013 4:10:30 PM - Zacks.com

WEEK AHEAD: Tech, Energy, Defense to Report Earnings Next Week
4/19/2013 3:44:00 PM - Dow Jones Business News

LabCorp Earnings Misses Again - Analyst Blog
4/19/2013 11:14:12 AM - Zacks.com

Positive Data on Lilly Diabetes Candidate - Analyst Blog
4/18/2013 3:17:53 PM - Zacks.com